MA25830A1 - Sel de tartrate d'un derive de thiazolidinedione. - Google Patents

Sel de tartrate d'un derive de thiazolidinedione.

Info

Publication number
MA25830A1
MA25830A1 MA27022A MA27022A MA25830A1 MA 25830 A1 MA25830 A1 MA 25830A1 MA 27022 A MA27022 A MA 27022A MA 27022 A MA27022 A MA 27022A MA 25830 A1 MA25830 A1 MA 25830A1
Authority
MA
Morocco
Prior art keywords
tartrate
salt
thiazolidinedione derivative
thiazolidinedione
derivative
Prior art date
Application number
MA27022A
Other languages
English (en)
French (fr)
Inventor
Andrew Simon Graig
Tim Chien Ting Ho
Michael Millan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MA25830A1 publication Critical patent/MA25830A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
MA27022A 2000-08-04 2003-02-03 Sel de tartrate d'un derive de thiazolidinedione. MA25830A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0019226.0A GB0019226D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
MA25830A1 true MA25830A1 (fr) 2003-07-01

Family

ID=9897028

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27022A MA25830A1 (fr) 2000-08-04 2003-02-03 Sel de tartrate d'un derive de thiazolidinedione.

Country Status (23)

Country Link
EP (1) EP1307448A1 (cs)
JP (1) JP2004505971A (cs)
KR (1) KR20030022356A (cs)
CN (1) CN1458930A (cs)
AP (1) AP2003002737A0 (cs)
AU (1) AU2001276508A1 (cs)
BG (1) BG107605A (cs)
BR (1) BR0112984A (cs)
CA (1) CA2417828A1 (cs)
CZ (1) CZ2003314A3 (cs)
EA (1) EA200300231A1 (cs)
EC (1) ECSP034468A (cs)
GB (1) GB0019226D0 (cs)
HU (1) HUP0300770A2 (cs)
IL (1) IL154277A0 (cs)
MA (1) MA25830A1 (cs)
MX (1) MXPA03001086A (cs)
NO (1) NO20030508L (cs)
OA (1) OA12355A (cs)
PL (1) PL360702A1 (cs)
SK (1) SK1452003A3 (cs)
WO (1) WO2002012233A1 (cs)
ZA (1) ZA200300962B (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
FR2845602B1 (fr) * 2002-10-11 2005-07-08 Servier Lab Association entre un ligand des recepteurs actives par les proliferateurs de peroxisomes et un agent antioxydant et les compositions pharmaceutiques qui les contiennent
US7264813B2 (en) 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
CN102532122B (zh) * 2010-12-29 2015-12-02 开封制药(集团)有限公司 酒石酸罗格列酮的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
AU2001276508A1 (en) 2002-02-18
BR0112984A (pt) 2003-06-10
JP2004505971A (ja) 2004-02-26
OA12355A (en) 2004-03-19
EP1307448A1 (en) 2003-05-07
NO20030508L (no) 2003-03-20
KR20030022356A (ko) 2003-03-15
GB0019226D0 (en) 2000-09-27
SK1452003A3 (en) 2004-05-04
WO2002012233A1 (en) 2002-02-14
HUP0300770A2 (hu) 2003-11-28
PL360702A1 (en) 2004-09-20
NO20030508D0 (no) 2003-01-31
CN1458930A (zh) 2003-11-26
CZ2003314A3 (cs) 2004-02-18
MXPA03001086A (es) 2003-05-27
BG107605A (bg) 2003-09-30
ZA200300962B (en) 2003-10-29
IL154277A0 (en) 2003-09-17
ECSP034468A (es) 2003-03-31
EA200300231A1 (ru) 2003-06-26
AP2003002737A0 (en) 2003-03-31
CA2417828A1 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
LU92890I2 (fr) Panobinstat ou un sel pharmaceutiquement acceptable, ou un dérivé de celui-ci (farydak)
LU92678I2 (fr) Tobramycine ou un sel pharmaceutiquement acceptable qui en dérive
LU93266I2 (fr) Sélexipag ou un sel de celui-ci
LU92702I2 (fr) Naloxegol ou un sel pharmaceutiquement acceptable de celui-ci (moventig)
LU92397I2 (fr) Vortioxétine ou un sel d'addition d'acide de celui-ci pharmaceutiquement acceptable
BR0000327B1 (pt) cabeÇa de poÇo.
DZ3001A1 (fr) Sel de potassium d'oméprazole-(S).
DE60138996D1 (de) Panoramakopf
DE60125004D1 (de) Verbesserte Reinigungsverfahren eines Druckkopfes
MA25898A1 (fr) SELS DE TARTRATE D'UN DERIVé DE THIAZOLIDINEDIONE.
MA25830A1 (fr) Sel de tartrate d'un derive de thiazolidinedione.
MA25832A1 (fr) Sel de tartrate d'un derive de thiazolidinedione.
MA25831A1 (fr) Sel de tartrate d'un derive de thiazolidinedione.
EG22745A (en) 2-(3,5-Disbustituted-4-pyridyl)-4-(thienyl) thiazolyl or arylphenyl)1,30xazoline compounds
ITGE20000030V0 (it) Erogatore per apparecchi respiratori subacquei.
ZA200205835B (en) Compounds useful for the treatment or prevention of a disease mediated by the alpha-2B-adrenoceptor.
IL151017A0 (en) Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor
FR2809397B1 (fr) Procede de preparation d'un compose de type benzofuranne ou benzothiophene
SI1305310T1 (sl) Tartratne soli derivata tiazolidindiona
IT1311483B1 (it) Tavolo per un gioco di bilie.
IT1314214B1 (it) Forma per getti di colatura.
FR2826662B1 (fr) Procede de preparation d'un sel de polyaniline
ITBO20020704A1 (it) Macchina, utilizzante cialde, per l'erogazione di